Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...
When building a strong brand identity, your logo is the star of the show. It’s often the first thing customers see, recognize ...
CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...
Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a ...